Aaron Mitchell completed his undergraduate training at the University of California, San Diego with a B.S. in Bioengineering: Biotechnology. Aaron is now a PhD student at Stanford University, continuing his studies in Bioengineering. Once at Stanford, Aaron joined a protein engineering lab, with a project focused on engineering novel protease inhibitors to stop the progression of metastatic cancer. While pursuing research, Aaron has lead the research training of three undergraduate students and one first year graduate student, and also helped lead two graduate level courses. Aaron has also completed an internship at AbbVie Biotherapeutics where he applied protein engineering skills he acquired at Stanford. His efforts helped engineer novel antibody fragments aimed to activate the human immune system to stop cancer progression. Aaron has also volunteered with the 49ers Academy and SPLASH, two organizations at Stanford focused on encouraging disadvantaged youth to learn and enjoy science.